Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Anionic linear-globular dendrimers: biocompatible hybrid materials with potential uses in nanomedicine.

Alavidjeh MS, Haririan I, Khorramizadeh MR, Ghane ZZ, Ardestani MS, Namazi H.

J Mater Sci Mater Med. 2010 Apr;21(4):1121-33. doi: 10.1007/s10856-009-3978-8. Epub 2010 Jan 16.

PMID:
20082119
2.

Anionic linear-globular dendrimer-cis-platinum (II) conjugates promote cytotoxicity in vitro against different cancer cell lines.

Haririan I, Alavidjeh MS, Khorramizadeh MR, Ardestani MS, Ghane ZZ, Namazi H.

Int J Nanomedicine. 2010 Feb 2;5:63-75.

3.

Blood compatibility of polyamidoamine dendrimers and erythrocyte protection.

Han MH, Chen J, Wang J, Chen SL, Wang XT.

J Biomed Nanotechnol. 2010 Feb;6(1):82-92.

PMID:
20499836
4.

Protective effect of PEGylation against poly(amidoamine) dendrimer-induced hemolysis of human red blood cells.

Wang W, Xiong W, Zhu Y, Xu H, Yang X.

J Biomed Mater Res B Appl Biomater. 2010 Apr;93(1):59-64. doi: 10.1002/jbm.b.31558.

PMID:
20186802
6.

Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery.

Najlah M, D'Emanuele A.

Curr Opin Drug Discov Devel. 2007 Nov;10(6):756-67. Review.

PMID:
17987527
7.

Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer.

Agashe HB, Dutta T, Garg M, Jain NK.

J Pharm Pharmacol. 2006 Nov;58(11):1491-8.

PMID:
17132212
8.

Biological Activity of Mesoporous Dendrimer-Coated Titanium Dioxide: Insight on the Role of the Surface-Interface Composition and the Framework Crystallinity.

Milowska K, Rybczyńska A, Mosiolek J, Durdyn J, Szewczyk EM, Katir N, Brahmi Y, Majoral JP, Bousmina M, Bryszewska M, El Kadib A.

ACS Appl Mater Interfaces. 2015 Sep 16;7(36):19994-20003. doi: 10.1021/acsami.5b04780. Epub 2015 Sep 2.

PMID:
26305597
9.

Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes.

Mishra V, Gupta U, Jain NK.

Pharmazie. 2010 Dec;65(12):891-5.

PMID:
21284258
10.

In vitro biological evaluation of high molecular weight hyperbranched polyglycerols.

Kainthan RK, Hester SR, Levin E, Devine DV, Brooks DE.

Biomaterials. 2007 Nov;28(31):4581-90. Epub 2007 Aug 3.

PMID:
17688941
11.

Surface modification of PAMAM dendrimer improves its biocompatibility.

Ciolkowski M, Petersen JF, Ficker M, Janaszewska A, Christensen JB, Klajnert B, Bryszewska M.

Nanomedicine. 2012 Aug;8(6):815-7. doi: 10.1016/j.nano.2012.03.009. Epub 2012 Apr 26.

PMID:
22542820
12.

Janus PEG-based dendrimers for use in combination therapy: controlled multi-drug loading and sequential release.

Acton AL, Fante C, Flatley B, Burattini S, Hamley IW, Wang Z, Greco F, Hayes W.

Biomacromolecules. 2013 Feb 11;14(2):564-74. doi: 10.1021/bm301881h. Epub 2013 Jan 18.

PMID:
23305104
13.

Selective cytotoxicity of PAMAM G5 core--PAMAM G2.5 shell tecto-dendrimers on melanoma cells.

Schilrreff P, Mundiña-Weilenmann C, Romero EL, Morilla MJ.

Int J Nanomedicine. 2012;7:4121-33. doi: 10.2147/IJN.S32785. Epub 2012 Jul 31.

14.

Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.

Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R.

J Control Release. 2000 Mar 1;65(1-2):133-48. Erratum in: J Control Release 2000 Aug 10;68(2):299-302.

PMID:
10699277
15.

New Ionic bis-MPA and PAMAM Dendrimers: A Study of Their Biocompatibility and DNA-Complexation.

Movellan J, González-Pastor R, Martín-Duque P, Sierra T, de la Fuente JM, Serrano JL.

Macromol Biosci. 2015 May;15(5):657-67. doi: 10.1002/mabi.201400422. Epub 2015 Jan 28.

PMID:
25631886
16.

Dendrimer-protein interactions versus dendrimer-based nanomedicine.

Shcharbin D, Shcharbina N, Dzmitruk V, Pedziwiatr-Werbicka E, Ionov M, Mignani S, de la Mata FJ, Gómez R, Muñoz-Fernández MA, Majoral JP, Bryszewska M.

Colloids Surf B Biointerfaces. 2017 Apr 1;152:414-422. doi: 10.1016/j.colsurfb.2017.01.041. Epub 2017 Jan 31. Review.

PMID:
28167455
17.

Oligoethylenimine-grafted polypropylenimine dendrimers as degradable and biocompatible synthetic vectors for gene delivery.

Russ V, Günther M, Halama A, Ogris M, Wagner E.

J Control Release. 2008 Dec 8;132(2):131-40. doi: 10.1016/j.jconrel.2008.09.003. Epub 2008 Sep 10.

PMID:
18812195
18.

Dendrimer biocompatibility and toxicity.

Duncan R, Izzo L.

Adv Drug Deliv Rev. 2005 Dec 14;57(15):2215-37. Epub 2005 Nov 16. Review.

PMID:
16297497
19.

In vitro mammalian cytotoxicological study of PAMAM dendrimers - towards quantitative structure activity relationships.

Mukherjee SP, Davoren M, Byrne HJ.

Toxicol In Vitro. 2010 Feb;24(1):169-77. doi: 10.1016/j.tiv.2009.09.014. Epub 2009 Sep 22.

PMID:
19778601
20.

Nanosilver based anionic linear globular dendrimer with a special significant antiretroviral activity.

Ardestani MS, Fordoei AS, Abdoli A, Ahangari Cohan R, Bahramali G, Sadat SM, Siadat SD, Moloudian H, Nassiri Koopaei N, Bolhasani A, Rahimi P, Hekmat S, Davari M, Aghasadeghi MR.

J Mater Sci Mater Med. 2015 May;26(5):179. doi: 10.1007/s10856-015-5510-7. Epub 2015 Apr 17.

PMID:
25893388

Supplemental Content

Support Center